SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) flares in adults. Administer SPEVIGO as a single 900 mg dose by intravenous infusion over 90 minutes. If GPP flare symptoms persist, an additional intravenous 900 mg dose (over 90 minutes) may be administered one week after the initial dose.